Despite the other NFE2L2 variants studied (rs6721961, rs6706649, and rs35652124) being linked with neoplasia development and other pathologies [25,26,27,28], in our study, we did not find any correlation between them and CML patients’ responses and prognoses. Here, NFE2L2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.